Articles
Tech · Biotechnology
ai designed gene switches cause dramatic tumor shrinkage in lab studies, investors and pharma rush to scale up
Breakthrough in the lab sharpens a race to industrialize programmable gene controls
In a string of preclinical reports and conference presentations over the past year, researchers working at the intersection of
new ai tool designs personalized cancer vaccines in 48 hours, sparking global funding sprint
Fast design, slow proof: investors rush after AI vaccine claim
A high-profile push to use artificial intelligence to design bespoke cancer vaccines in 48 hours has set off a rapid wave